Malaysian Health Technology Assessment Section, Medical Development Division, also known as MaHTAS produces health technology assessments, clinical practice guidelines and other synthesized research evidence which are transparent, relevant and easily accessible to serve as an input for decision and policy making with regards to health technologies such as procurement, adoption, implementation, disengagement, reimbursement and pricing.